Impact of Antithyroperoxidase Antibodies (Anti-TPO) on Ovarian Reserve and Early Embryo Development in Assisted Reproductive Technology Cycles

Int J Mol Sci. 2023 Feb 28;24(5):4705. doi: 10.3390/ijms24054705.

Abstract

Autoimmune thyroid disease (AITD) is one of the most common endocrinopathies and is more prevalent in women. It becomes evident that the circulating antithyroid antibodies that often follow AITD have effects on many tissues, including ovaries, and therefore that this common morbidity might have an impact on female fertility, the investigation of which is the aim of the present research. Ovarian reserve, ovarian response to stimulation and early embryo development in infertile patients with thyroid autoimmunity were assessed in 45 women with thyroid autoimmunity and 45 age-matched control patients undergoing infertility treatment. It was demonstrated that the presence of anti-thyroid peroxidase antibodies is associated with lower serum anti-Müllerian hormone levels and antral follicle count. Further investigation revealed the higher prevalence of sub-optimal response to ovarian stimulation in TAI-positive women, lower fertilization rate and lower number of high-quality embryos in this group of patients. The cut-off value for follicular fluid anti-thyroid peroxidase antibody affecting the above-mentioned parameters was determined to be 105.0 IU/mL, highlighting the necessity of closer monitoring in couples seeking infertility treatment with ART.

Keywords: AT-TPO; IVF; embryo; follicular fluid; infertility; ovarian reserve; thyroid autoimmunity.

MeSH terms

  • Autoantibodies* / immunology
  • Embryonic Development* / immunology
  • Female
  • Humans
  • Infertility, Female* / etiology
  • Infertility, Female* / therapy
  • Iodide Peroxidase* / immunology
  • Ovarian Reserve* / immunology
  • Sperm Injections, Intracytoplasmic*
  • Thyroiditis, Autoimmune* / complications

Substances

  • anti-thyroid autoantibodies
  • Autoantibodies
  • TPO protein, human
  • Iodide Peroxidase